STERIS closed at $247.91 on Nov 4, up 7.16%, 7.7% below its 52-week closing high. Volume of 1.4M shares was 1.98× its 20-day average (above normal).
Split-adjusted performance: +18.8% over one month, +15.6% over six months, +4.5% over one year.
In the quarter ended Jun 30, 2026, revenue was $1.49B, up 7.3% from a year earlier, with a net margin of 13.4%.
Short interest was 2.4M shares at the Oct 15 settlement, down 16.1% from the prior report (2.5% of float, 3.6 days to cover).